Kailera Therapeutics appoints Kathleen Tregoning as Chief Corporate Affairs Officer

GlobeNewswire·29 Jun 2026·Read original

2▲1 ▼0Impact / 5

Summary · why it matters

Kailera Therapeutics has appointed Kathleen Tregoning as Chief Corporate Affairs Officer. Tregoning brings more than two decades of experience leading global corporate affairs organizations, most recently serving as Chief Corporate Affairs Officer and Head of Commercial Strategy at Cerevel Therapeutics. She previously held senior roles at Sanofi and Biogen, and began her career as a health policy staff member for multiple committees of the United States Congress. Kailera is a clinical-stage biotechnology company advancing four clinical-stage product candidates for obesity, with its lead candidate ribupatide injection in global Phase 3 trials.

Kailera Therapeutics, Inc. Common Stock ▲